GOunder/Desmoid Tumor Research Foundation DEsmoid Symptom/Impact Scale (GODDESS©): psychometric properties and clinically meaningful thresholds as assessed in the Phase 3 DeFi randomized controlled clinical trial.
Saved in:
| Title: | GOunder/Desmoid Tumor Research Foundation DEsmoid Symptom/Impact Scale (GODDESS©): psychometric properties and clinically meaningful thresholds as assessed in the Phase 3 DeFi randomized controlled clinical trial. |
|---|---|
| Authors: | Gounder MM; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Atkinson TM; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bell T; SpringWorks Therapeutics, Inc., Stamford, CT, USA. Timothy.Bell@springworkstx.com., Daskalopoulou C; IQVIA, Patient-Centered Solutions, Athens, Greece., Griffiths P; Patient-Centered Solutions, IQVIA, Paris, France., Martindale M; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Smith LM; SpringWorks Therapeutics, Inc., Stamford, CT, USA., Lim A; SpringWorks Therapeutics, Inc., Stamford, CT, USA. |
| Source: | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2023 Oct; Vol. 32 (10), pp. 2861-2873. Date of Electronic Publication: 2023 Jun 22. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer Netherlands Country of Publication: Netherlands NLM ID: 9210257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2649 (Electronic) Linking ISSN: 09629343 NLM ISO Abbreviation: Qual Life Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
